Japan Times, Aug 5, 2024
The health ministry is considering expanding the availability of the country's first approved abortion pill, the Mefeego pill pack, to allow clinics without inpatient facilities to use it.
Currently, the medication can only be administered in hospitals with inpatient capabilities. Following a national survey indicating no severe complications since its approval in April last year, the ministry is aiming to allow its use in outpatient clinics that can provide 24-hour care and coordinate with inpatient facilities for emergencies.
Continued: https://www.japantimes.co.jp/news/2024/08/05/japan/society/abortion-pill-clinics/
In Japan, the second drug, misoprostol, cannot be administered repeatedly. This is because Misoprostol is designated as a "poison".
In addition, the price of an abortion using the Mifepristone & Misoprostol combination pack in Japan is set at around 100,000 yen. In some cases, this is higher than a surgical abortion.
